Here’s one bullish, one bearish, and one foolproof bet.
There could very well be a lot more upside near and long-term.
Shares are pausing after the company reported earnings. Here’s a cheap upside bet if resistance gives way in the stock.
So long as folks continue to spend more time indoors sprucing up their houses and avoiding public places– the trend should continue.
Biotech stocks find themselves in a very interesting, and potentially very profitable, situation right now… but not all of them are worth buying.
Don’t buy (or sell) it based on the pandemic’s impact on it right now… instead, realize it’s at the epicenter of a new trend.
Our target potential upside is 17% to 55% in the next 4-6 months.
It’s my “Option Trade of the Day”.
Here are today’s upgrades and downgrades: TrueCar, Callaway Golf, Universal Display, Allianz, Carvana and more.
Micro-cap stocks can be potential multi-baggers. Here are three lesser known names worth holding for the long term.